The number of BPH procedures performed in 2016 was 671,307 and by 2023, it is expected to reach 782,411. Growing aging population, rising prevalence of BPH, rise in the awareness of BPH disorders and surge in the adoption of minimally invasive procedures are the major factors driving the use of BPH procedures.

Access Detailed Report Summary at: https://www.psmarketresearch.com/market-analysis/benign-prostatic-hyperplasia-procedures

In terms of type, the BPH procedures is categorized into surgical procedures, laser based procedures and other energy based procedures. The surgical procedure accounted for the largest number of BPH procedures, contributing 58.3% in 2016. The number of laser based procedure is expected to register fastest growth during the forecast period. Laser based procedure are as effective as surgical procedures and reduce the hospital stay time.

Download Report Sample at: https://www.psmarketresearch.com/market-analysis/benign-prostatic-hyperplasia-procedures/report-sample

In terms of end-users, the BPH procedures is categorized into hospitals, specialty clinics and ambulatory surgery centers. Hospitals accounted for the most number of BPH procedures in 2016. In 2016, 78.8% of the total BPH procedures were performed in hospitals and 15.9% BPH procedures were performed in specialty clinics. Ambulatory surgical centers are another key end user for BPH procedures, which is expected to witness the highest inflow of BPH patients for treatment during the forecast period. The development of technologically advanced BPH procedures and high BPH prevalence is leading to the growth in the number of patients treated in the ambulatory surgical centers.

In North America, every year, September is observed as National Prostate Health Month by health experts, health advocates, and individuals concerned with the prostate health of men. The main purpose of designating a whole month for prostate health is to create awareness, educate people about the risk factors and symptoms of prostate related diseases and other factors. Several campaigns were launched by the players in the market to make people aware about the prostate related diseases. In December 2016, GlaxoSmithKline plc launched a campaign ‘#SeatsupforSanta’, to spread awareness about BPH symptoms and treatments. All the aforementioned initiatives lead to the growth in the number of patients opting for BPH treatment.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=benign-prostatic-hyperplasia-procedures

Some of the key players operating in the BPH procedures include NxThera, Inc., Boston Scientific Corporation, Urologix, LLC., Karl Storz GmbH & Co. KG, Lumenis Ltd., Olympus Corporation, Advin Urology, Convergent Laser Technologies, Richard Wolf GmbH, and Medtronic Plc.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
Web: https://www.psmarketresearch.com